• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The molecular basis for hereditary porcine membranoproliferative glomerulonephritis type II: point mutations in the factor H coding sequence block protein secretion.遗传性猪II型膜增生性肾小球肾炎的分子基础:补体因子H编码序列中的点突变阻碍蛋白质分泌。
Am J Pathol. 2002 Dec;161(6):2027-34. doi: 10.1016/S0002-9440(10)64481-1.
2
Porcine membranoproliferative glomerulonephritis type II: an autosomal recessive deficiency of factor H.猪II型膜增生性肾小球肾炎:一种常染色体隐性遗传性H因子缺乏症。
Vet Rec. 1995 Sep 2;137(10):240-4. doi: 10.1136/vr.137.10.240.
3
Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency.遗传性猪II型膜增生性肾小球肾炎由补体H因子缺乏引起。
J Clin Invest. 1995 Mar;95(3):1054-61. doi: 10.1172/JCI117751.
4
Extensive complement activation in hereditary porcine membranoproliferative glomerulonephritis type II (porcine dense deposit disease).遗传性猪II型膜增生性肾小球肾炎(猪致密物沉积病)中的广泛补体激活
Am J Pathol. 1993 Nov;143(5):1356-65.
5
Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II).因子H调节域4中赖氨酸224的缺失揭示了致密物沉积病(MPGN II型)的一种新发病机制。
Kidney Int. 2006 Jul;70(1):42-50. doi: 10.1038/sj.ki.5000269. Epub 2006 Apr 12.
6
Eradication of porcine factor H deficiency in Norway.挪威根除猪因子H缺乏症。
Vet Rec. 1997 Apr 12;140(15):392-5. doi: 10.1136/vr.140.15.392.
7
Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies.获得性和遗传性补体异常在致密物沉积病和其他 C3 肾小球疾病中起着关键作用。
Kidney Int. 2012 Aug;82(4):454-64. doi: 10.1038/ki.2012.63. Epub 2012 Mar 28.
8
Gene polymorphism of complement factor H in a Turkish patient with membranoproliferative glomerulonephritis type II.一名患有II型膜增生性肾小球肾炎的土耳其患者的补体因子H基因多态性
Iran J Kidney Dis. 2012 Mar;6(2):149-53.
9
Porcine membranoproliferative glomerulonephritis with intramembranous dense deposits (porcine dense deposit disease).伴有膜内致密沉积物的猪膜增生性肾小球肾炎(猪致密物沉积病)
APMIS. 1993 Apr;101(4):281-9. doi: 10.1111/j.1699-0463.1993.tb00112.x.
10
Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease).补体调节基因H因子(CFH)和H因子相关蛋白5(CFHR5)的变异与II型膜增生性肾小球肾炎(致密物沉积病)相关。
J Med Genet. 2006 Jul;43(7):582-9. doi: 10.1136/jmg.2005.038315. Epub 2005 Nov 18.

引用本文的文献

1
C3 glomerulopathy: a kidney disease mediated by alternative pathway deregulation.C3肾小球病:一种由替代途径失调介导的肾脏疾病。
Front Nephrol. 2024 Oct 29;4:1460146. doi: 10.3389/fneph.2024.1460146. eCollection 2024.
2
Renal diseases and the role of complement: Linking complement to immune effector pathways and therapeutics.肾脏疾病与补体的作用:将补体与免疫效应途径和治疗联系起来。
Adv Immunol. 2021;152:1-81. doi: 10.1016/bs.ai.2021.09.001. Epub 2021 Nov 19.
3
A case of C3 glomerulonephritis successfully treated with eculizumab.1例用依库珠单抗成功治疗的C3肾小球肾炎病例。
Pediatr Nephrol. 2015 Jun;30(6):1033-7. doi: 10.1007/s00467-015-3061-2. Epub 2015 Mar 22.
4
Is renal function associated with early age-related macular degeneration?肾功能与早期年龄相关性黄斑变性有关吗?
Optom Vis Sci. 2014 Aug;91(8):860-4. doi: 10.1097/OPX.0000000000000288.
5
Dense deposit disease and C3 glomerulopathy.致密物沉积病和 C3 肾小球病。
Semin Nephrol. 2013 Nov;33(6):493-507. doi: 10.1016/j.semnephrol.2013.08.002.
6
Making sense of the spectrum of glomerular disease associated with complement dysregulation.理解与补体调节异常相关的肾小球疾病谱。
Pediatr Nephrol. 2014 Oct;29(10):1883-94. doi: 10.1007/s00467-013-2559-8. Epub 2013 Jul 14.
7
Recent insights into C3 glomerulopathy.C3 肾小球病的最新认识。
Nephrol Dial Transplant. 2013 Jul;28(7):1685-93. doi: 10.1093/ndt/gfs430. Epub 2013 Mar 10.
8
Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies.依库珠单抗在非典型溶血尿毒综合征和 C3 肾小球病中的应用。
Nat Rev Nephrol. 2012 Nov;8(11):643-57. doi: 10.1038/nrneph.2012.214. Epub 2012 Oct 2.
9
Dense deposit disease.致密物沉积病。
Mol Immunol. 2011 Aug;48(14):1604-10. doi: 10.1016/j.molimm.2011.04.005. Epub 2011 May 24.
10
Disease-associated N-terminal complement factor H mutations perturb cofactor and decay-accelerating activities.与疾病相关的 N 端补体因子 H 突变扰乱了辅助因子和衰变加速因子的活性。
J Biol Chem. 2011 Apr 1;286(13):11082-90. doi: 10.1074/jbc.M110.211839. Epub 2011 Jan 26.

本文引用的文献

1
Rat complement factor H: molecular cloning, sequencing and quantification with a newly established ELISA.大鼠补体因子H:分子克隆、测序及用新建立的酶联免疫吸附测定法进行定量分析
Scand J Immunol. 2002 Aug;56(2):149-60. doi: 10.1046/j.1365-3083.2002.01098.x.
2
Combined kidney and liver transplantation for familial haemolytic uraemic syndrome.家族性溶血性尿毒症综合征的肝肾联合移植
Lancet. 2002 May 11;359(9318):1671-2. doi: 10.1016/S0140-6736(02)08560-4.
3
Complement factor H and the haemolytic uraemic syndrome.补体因子H与溶血尿毒综合征
Lancet. 2001 Oct 13;358(9289):1200-2. doi: 10.1016/s0140-6736(01)06339-5.
4
Hemolytic-uremic syndrome and complement factor H deficiency: clinical aspects.溶血尿毒综合征与补体因子H缺乏:临床方面
Semin Thromb Hemost. 2001 Jun;27(3):185-90. doi: 10.1055/s-2001-15247.
5
Hemolytic uremic syndrome: how do factor H mutants mediate endothelial damage?溶血尿毒综合征:补体因子H突变体如何介导内皮损伤?
Trends Immunol. 2001 Jul;22(7):345-8. doi: 10.1016/s1471-4906(01)01972-x.
6
Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition.溶血尿毒综合征中的补体因子H突变集中在外显子18至20,这是一个对宿主细胞识别很重要的结构域。
Am J Hum Genet. 2001 Feb;68(2):485-90. doi: 10.1086/318203. Epub 2001 Jan 17.
7
Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome.非典型溶血性尿毒症综合征中因子H C末端区域错义突变的聚集
Am J Hum Genet. 2001 Feb;68(2):478-84. doi: 10.1086/318201. Epub 2001 Jan 17.
8
The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20.家族性溶血性尿毒症综合征的分子基础:补体因子H基因的突变分析揭示了短共有重复序列20中的一个热点。
J Am Soc Nephrol. 2001 Feb;12(2):297-307. doi: 10.1681/ASN.V122297.
9
Factor H and the pathogenesis of renal diseases.补体因子H与肾脏疾病的发病机制。
Pediatr Nephrol. 2000 Sep;14(10-11):1045-53. doi: 10.1007/s004670050069.
10
Each of the three binding sites on complement factor H interacts with a distinct site on C3b.补体因子H上的三个结合位点中的每一个都与C3b上的一个不同位点相互作用。
J Biol Chem. 2000 Sep 8;275(36):27657-62. doi: 10.1074/jbc.M002903200.

遗传性猪II型膜增生性肾小球肾炎的分子基础:补体因子H编码序列中的点突变阻碍蛋白质分泌。

The molecular basis for hereditary porcine membranoproliferative glomerulonephritis type II: point mutations in the factor H coding sequence block protein secretion.

作者信息

Hegasy Guido A, Manuelian Tamara, Hogasen Kolbjorn, Jansen Johan H, Zipfel Peter F

机构信息

Research Group for Biomolecular Medicine, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.

出版信息

Am J Pathol. 2002 Dec;161(6):2027-34. doi: 10.1016/S0002-9440(10)64481-1.

DOI:10.1016/S0002-9440(10)64481-1
PMID:12466119
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1850924/
Abstract

Porcine membranoproliferative glomerulonephritis type II in piglets of the Norwegian Yorkshire breed is considered the first animal model of human dense deposit disease. Porcine dense deposit disease is caused by the absence of the complement regulator factor H in plasma. Here we report the molecular basis for this absence. Single nucleotide exchanges at position C1590G and T3610G in the coding region of the factor H gene result in amino acid exchanges at nonframework residues L493V and I1166R that are located within SCR 9 and SCR 20, respectively. Apparently the L493V mutation represents a polymorphism whereas the I1166R causes the physiological consequences a block in protein secretion. Expression analysis shows comparable mRNA levels for factor H in liver tissue derived from both affected and healthy animals. In affected piglets, factor H protein is detected in increased amounts in liver cells. Factor H accumulates inside the hepatocytes and is not released as shown by Western blot analysis and immunohistochemistry. These data demonstrate that single amino acid exchanges of two nonframework amino acids either alone or in combination block protein secretion of factor H. This observation is also of interest for other human diseases in which factor H is involved, such as human factor H-associated form of hemolytic uremic syndrome.

摘要

挪威约克夏品种仔猪的II型猪膜增生性肾小球肾炎被认为是人类致密物沉积病的首个动物模型。猪致密物沉积病是由血浆中补体调节因子H缺失所致。在此我们报告了这种缺失的分子基础。因子H基因编码区的C1590G和T3610G位点的单核苷酸交换分别导致位于SCR 9和SCR 20内的非构架残基L493V和I1166R处的氨基酸交换。显然,L493V突变代表一种多态性,而I1166R导致了生理后果——蛋白质分泌受阻。表达分析显示,来自患病和健康动物的肝脏组织中因子H的mRNA水平相当。在患病仔猪中,肝细胞中检测到的因子H蛋白量增加。如蛋白质印迹分析和免疫组织化学所示,因子H在肝细胞内积聚且未释放。这些数据表明,两个非构架氨基酸的单氨基酸交换单独或共同作用会阻碍因子H的蛋白质分泌。这一观察结果对于其他涉及因子H的人类疾病也具有重要意义,比如人类因子H相关型溶血尿毒综合征。